Post-Traumatic Scar
Conditions
Brief summary
Compare different minimally invasive approaches to reach optimum improvement by comparing the efficacy and safety of both combined subcision with platelet-rich plasma and microneedling versus combined subcision with saline and microneedling in the treatment of post-traumatic scars.
Detailed description
The scars at the level of the skin represent a normal and inevitable process of healing traumatic or surgical lesions, but except for the appearance of the skin, they also have a profound psychological impact . Thus, people with scars try to integrate them into their sense of self to gain psychological acceptance . Many treatment options have been developed for the management of traumatic scars .Surgical intervention is an invasive technique, surgery has a high risk of inducing new scar formation . Non-surgical approaches for the treatment of traumatic scars include topical treatments and minimally invasive approached as subcision,microneedling and laser. Autologous platelet-rich plasma is plasma with a higher concentration of platelets than normally found, it can enhance wound healing which has been demonstrated in controlled studies for soft and hard tissues . The application of autologous platelet-rich plasma to surgical wounds has been shown to accelerate tissue repair and reduce postoperative pain . Subcision is a procedure in which a needle is inserted under the skin and passed in multiple directions . Although subcision is adequate as a stand-alone treatment, improved results are achieved when it is combined with other modalities. Microneedling is a percutaneous collagen induction therapy that causes skin resurfacing. It involves using fine needles to create controlled microdermal injuries starting a complex cascade of growth factors that end in collagen remodeling . Because of the different treatment options available for this common problem, the current work aimed to combine and compare different minimally invasive approaches to reach optimum improvement.
Interventions
minimally invasive procedures
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients with posttraumatic scars * Age more than 12 years
Exclusion criteria
* Patients with platelet or blood clotting disorders, and chronic liver or autoimmune diseases. * Patients with chronic debilitating diseases, uncontrolled systemic infection, or keloid tendency or with unrealistic expectations. * Pregnant females. * Patients who did not complete the treatment sessions or the follow-up period.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Scar severity grading | after 1 month of treatment completion. | Scar severity grading will be evaluated by blinded dermatologist |
Countries
Egypt